Edgewise Therapeutics, Inc. (EWTX)
30.22
+0.10
(+0.33%)
USD |
NASDAQ |
Feb 26, 15:28
Edgewise Therapeutics Gross Profit (Quarterly) : -0.57M for Sept. 30, 2025
Gross Profit (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Quarterly) Benchmarks
| Glaukos Corp. | 111.35M |
| Nuvalent, Inc. | 0.00 |
| Neurocrine Biosciences, Inc. | 787.90M |
| Dynavax Technologies Corp. (DELISTED) | 80.47M |
| Omeros Corp. | -0.24M |